PET Guerrilla

A former Uruguayan antigovernment rebel is developing a revolutionary diagnostic tool for Alzheimer’s disease.

Written byChris Tachibana
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Former guerrilla leader Henry Engler (left) talks to Uruguayan President José Mujica at the launch of CUDIM in Montevideo last year.IVAN FRANCO / EPA / CORBIS

In August 1972, Uruguayan medical student Henry Engler’s education was interrupted. He was shot in the shoulder, arrested for being a Tupamaro antigovernment urban guerrilla, and imprisoned for 13 years—11 in solitary confinement.

Engler says he joined the Tupamaros because government corruption was affecting health conditions in the country. “As medical students, we were not able to help patients,” he says. “When we tried to get more resources, the police shot and killed students.” In 1985, a new democratic government gave amnesty to political prisoners, including Engler, then close to 40. “I was in bad condition after 13 years in prison,” he says. “My brother was living in Sweden, and I was invited by the Swedish government to move there to improve my health.”

Engler ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies